Group One Trading
LUMO

Group One Trading’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Group One Trading’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,600
Closed -$26K – 6632
2020
Q2 		$26K Sell
1,600
-31,800
-95% -$379K ﹤0.01% 4714
2020
Q1 		$284K Buy
33,400
+16,422
+97% +$230K ﹤0.01% 2471
2019
Q4 		$387K Buy
16,978
+4,567
+37% +$65.1K ﹤0.01% 2648
2019
Q3 		$178K Buy
+12,411
New +$182K ﹤0.01% 3165
2019
Q2 		– Sell
-156
Closed -$3K – 5485
2019
Q1 		$3K Buy
+156
New +$2.33K ﹤0.01% 4542
2018
Q3 		– Sell
-4,422
Closed -$189K – 5690
2018
Q2 		$189K Sell
4,422
-6,967
-61% -$319K ﹤0.01% 3095
2018
Q1 		$743K Sell
11,389
-3,689
-24% -$261K 0.01% 1738
2017
Q4 		$1.1M Sell
15,078
-5,755
-28% -$476K 0.01% 1626
2017
Q3 		$1.91M Buy
20,833
+1,933
+10% +$148K 0.02% 1083
2017
Q2 		$1.25M Buy
18,900
+9,600
+103% +$1.19M 0.01% 1283
2017
Q1 		$2.02M Sell
9,300
-6,644
-42% -$949K 0.02% 861
2016
Q4 		$1.48M Sell
15,944
-13,067
-45% -$1.47M 0.01% 1090
2016
Q3 		$3.92M Sell
29,011
-28,767
-50% -$2.86M 0.04% 513
2016
Q2 		$5.86M Buy
57,778
+54,600
+1,718% +$6.77M 0.07% 328
2016
Q1 		$521K Sell
3,178
-1,055
-25% -$214K 0.01% 1660
2015
Q4 		$1.39M Sell
4,233
-5,311
-56% -$1.73M 0.02% 1093
2015
Q3 		$3.08M Sell
9,544
-7,667
-45% -$3.37M 0.04% 556
2015
Q2 		$6.86M Buy
17,211
+5,378
+45% +$2.29M 0.1% 229
2015
Q1 		$5.83M Buy
11,833
+3,455
+41% +$1.34M 0.09% 211
2014
Q4 		$3M Sell
8,378
-1,511
-15% -$450K 0.05% 453
2014
Q3 		$1.91M Sell
9,889
-2,444
-20% -$537K 0.03% 717
2014
Q2 		$2.95M Sell
12,333
-6,923
-36% -$1.41M 0.05% 507
2014
Q1 		$4.92M Sell
19,256
-1,855
-9% -$567K 0.08% 233
2013
Q4 		$4.18M Sell
21,111
-8,845
-30% -$1.57M 0.06% 315
2013
Q3 		$5.06M Buy
29,956
+18,156
+154% +$2.92M 0.1% 212
2013
Q2 		$2.09M Buy
+11,800
New +$1.67M 0.05% 403

Other funds holding LUMO

Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.45B AUM 39.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Group One Trading's LUMO Position: Q2 2024 in Review

Group One Trading sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q2 2024, closing a stake of 150 shares — an estimated $423 sold.

Group One Trading first reported a position in LUMO in Q4 2013 and held it in 36 quarters. The position peaked at $3.35M in Q1 2015. 35 funds tracked by Wall St. Rank hold LUMO as of Q2 2024.

  • Group One Trading reported no remaining Lumos Pharma, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Group One Trading sold 150 Lumos Pharma, Inc. Common Stock shares in Q2 2024, an estimated $423.
  • Group One Trading first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2013 and held it in 36 quarters.
  • Group One Trading's Lumos Pharma, Inc. Common Stock position peaked at $3.35M in Q1 2015.
  • 35 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q2 2024.

Based on Group One Trading's 13F filing for Q2 2024, filed 14 Aug 2024.